PMC:4161609 / 1462-2037 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4161609","sourcedb":"PMC","sourceid":"4161609","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4161609","text":"The frequency of daytime phlegm or losing the sense of smell had a positive correlation with FeNO levels in asthmatic patients taking controller medication. Upper abdominal symptoms, as well as symptoms suggesting rhinitis, were well correlated with asthma symptoms. However, neither upper abdominal symptoms nor rhinitis symptoms increased FeNO levels, which reflect eosinophilic airway inflammation during treatment for asthma. On the other hand, the degree of upper abdominal symptoms or dyspepsia symptoms had a weak but significant negative correlation with FeNO levels.","tracks":[]}